Subbu Nambi
Stock Analyst at Guggenheim
(4.37)
# 361
Out of 5,049 analysts
48
Total ratings
64.1%
Success rate
15.56%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintains: Buy | $115 → $170 | $139.10 | +22.21% | 2 | Oct 29, 2025 | |
| RVTY Revvity | Initiates: Neutral | n/a | $93.89 | - | 1 | Oct 16, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $20 | $17.24 | +16.04% | 1 | Sep 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $80 → $95 | $88.40 | +7.47% | 4 | Sep 26, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $67 | $97.79 | -31.49% | 6 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $30.59 | +17.69% | 2 | Aug 13, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $215.15 | +16.20% | 2 | Jul 23, 2025 | |
| NEOG Neogen | Maintains: Buy | $13 → $10 | $6.18 | +61.94% | 3 | Jun 30, 2025 | |
| ILMN Illumina | Maintains: Buy | $122 → $114 | $119.34 | -4.47% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $31.17 | +60.41% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $9.09 | +10.01% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $72.53 | -17.28% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.74 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $37 | $36.83 | +0.46% | 3 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $40.60 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $202.79 | -1.38% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $86.17 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $4.89 | +22.70% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.72 | +248.84% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.79 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $150.67 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $30.78 | -18.78% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.20 | - | 1 | Dec 14, 2023 |
GeneDx Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $139.10
Upside: +22.21%
Revvity
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $93.89
Upside: -
Adaptive Biotechnologies
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $17.24
Upside: +16.04%
Tempus AI
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $88.40
Upside: +7.47%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $56 → $67
Current: $97.79
Upside: -31.49%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $30.59
Upside: +17.69%
Danaher
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $215.15
Upside: +16.20%
Neogen
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $6.18
Upside: +61.94%
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $119.34
Upside: -4.47%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $31.17
Upside: +60.41%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $9.09
Upside: +10.01%
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $72.53
Upside: -17.28%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $6.74
Upside: -
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $36.83
Upside: +0.46%
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $40.60
Upside: -
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $202.79
Upside: -1.38%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $86.17
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.89
Upside: +22.70%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $1.72
Upside: +248.84%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.79
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $150.67
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $30.78
Upside: -18.78%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.20
Upside: -